The Asthma Impairment and Risk Questionnaire (AIRQ®) Predicts Exacerbation Risk in Patients With Mild-to-Moderate and Severe Disease

J. Reibman, B.E. Chipps, D.A. Beuther, R.S. Zeiger, R.A. Wise, W. McCann, M. George, I.A. Gilbert, J.M. Eudicone, H.N. Gandhi,G. Harding, K.R. Murphy

D21. TERMINATOR: CONTROL OF AIRWAY INFLAMMATION AND IMMUNE RESPONSE IN ASTHMA（2024）

引用 0|浏览0